MyFinsight
Home
Blog
About
Contact
Download
Download image
Sale of common stock
via atm program, net...
$3,208,116
Net proceeds from
exercise of remaining...
$145,000
Net cash provided by
(used in) financing...
$3,353,116
Net increase
(decrease) in cash
$681,877
Canceled cashflow
$2,671,239
Stock-based compensation
$1,544,214
Unreimbursed expenses
related party (accrued)
$123,982
Net cash used in
operating activities
-$2,671,239
Canceled cashflow
$1,668,196
Net loss
-$4,151,845
Accounts payable
-$187,590
Back
Back
Cash Flow
source: myfinsight.com
Greenwich LifeSciences, Inc. (GLSI)
Greenwich LifeSciences, Inc. (GLSI)